News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
304,412 Results
Type
Article (14452)
Company Profile (308)
Press Release (289652)
Section
Business (90984)
Career Advice (272)
Deals (18237)
Drug Delivery (34)
Drug Development (52573)
Employer Resources (33)
FDA (6442)
Job Trends (6213)
News (164843)
Policy (11881)
Tag
Academia (951)
Alliances (24918)
Alzheimer's disease (805)
Approvals (6414)
Artificial intelligence (67)
Bankruptcy (154)
Best Places to Work (5481)
Biotechnology (250)
Breast cancer (105)
Cancer (886)
Cardiovascular disease (68)
Career advice (235)
CAR-T (69)
Cell therapy (214)
Clinical research (41934)
Collaboration (286)
Compensation (125)
COVID-19 (1042)
C-suite (79)
Cystic fibrosis (68)
Data (995)
Diabetes (85)
Diagnostics (1758)
Earnings (32765)
Events (52543)
Executive appointments (251)
FDA (6819)
Funding (313)
Gene editing (64)
Gene therapy (163)
GLP-1 (315)
Government (1200)
Healthcare (7689)
Infectious disease (1080)
Inflammatory bowel disease (98)
IPO (9876)
Job creations (1009)
Job search strategy (213)
Layoffs (191)
Legal (2085)
Lung cancer (126)
Lymphoma (58)
Manufacturing (84)
Medical device (3959)
Medtech (3960)
Mergers & acquisitions (8523)
Metabolic disorders (252)
Neuroscience (1052)
NextGen Class of 2024 (2670)
Non-profit (966)
Northern California (1117)
Obesity (139)
Opinion (92)
Parkinson's disease (74)
Patents (65)
People (28328)
Phase I (14642)
Phase II (19457)
Phase III (12476)
Pipeline (372)
Postmarket research (923)
Preclinical (6134)
Radiopharmaceuticals (213)
Rare diseases (201)
Real estate (1820)
Regulatory (9333)
Research institute (1013)
Southern California (1010)
Startups (2199)
United States (9271)
Vaccines (170)
Weight loss (80)
Date
Today (84)
Last 7 days (457)
Last 30 days (1843)
Last 365 days (22470)
2024 (21892)
2023 (24784)
2022 (30172)
2021 (31686)
2020 (27286)
2019 (19591)
2018 (14384)
2017 (15965)
2016 (13762)
2015 (17031)
2014 (12316)
2013 (9194)
2012 (9434)
2011 (9269)
2010 (8889)
Location
Africa (154)
Arizona (63)
Asia (18951)
Australia (3083)
California (2550)
Canada (818)
China (202)
Colorado (91)
Connecticut (109)
Europe (38993)
Florida (302)
Georgia (80)
Illinois (162)
Indiana (91)
Maryland (355)
Massachusetts (2005)
Michigan (96)
Minnesota (111)
New Jersey (666)
New York (715)
North Carolina (493)
Northern California (1117)
Ohio (88)
Pennsylvania (510)
South America (250)
Southern California (1010)
Texas (319)
Washington State (263)
304,412 Results for "aegis therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aegis Sciences Corporation Announces Updates for NPS Testing
December 10, 2024
·
2 min read
Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference
Chemomab Therapeutics Ltd., a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, announced that Chief Executive Officer Dr. Adi Mor will deliver a corporate presentation at the Aegis Virtual Conference on May 7, 2024 at 9:00 am ET. Dr. Mor’s presentation will be webcast live.
May 2, 2024
·
1 min read
Press Releases
ITF Therapeutics LLC Announces Appointment of Erica L. Monaco, CPA, as Chief Operating Officer
December 4, 2024
·
7 min read
Business
Aegis Life Receives Investment to Continue Development of DNA-Encoded Therapeutic Antibodies Against Infectious Diseases Using the Fusogenix PLV Platform
Aegis Life receives a program-related investment of $4.45M from the Bill & Melinda Gates Foundation.
March 19, 2024
·
6 min read
BioMidwest
Ocuphire Pharma to Present at the Aegis Virtual Conference
Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and refractive eye disorders, today announced that George Magrath, M.D. M.B.A., M.S., Chief Executive Officer of Ocuphire, will present a company overview at the Aegis Virtual Conference being held May 7-9, 2024.
May 3, 2024
·
2 min read
Press Releases
Prime Therapeutics LLC earns certification from the National Committee for Quality Assurance
October 3, 2024
·
2 min read
Genetown
Strategic Acquisition Opportunity: Biotechnology Intellectual Property of Civetta Therapeutics, LLC Now Open for Bids
The Assignee of Civetta Therapeutics, LLC, a trailblazer in the field of biotechnology with a focus on β-propeller protein research, is inviting bids for the company’s rich portfolio of intellectual property.
April 4, 2024
·
2 min read
Drug Development
CSL Announces Top-line Results from the Phase 3 AEGIS-II Trial Evaluating the Efficacy and Safety of CSL112 (apolipoprotein A-I [human])
Global biotechnology leader CSL announced top-line results from the Phase 3 AEGIS-II trial evaluating the efficacy and safety of CSL112 compared to placebo in reducing the risk of major adverse cardiovascular events in patients following an acute myocardial infarction.
February 11, 2024
·
3 min read
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
Press Releases
Aegis Life and Entos Complete Phase 1 Enrollment of Clinical Trial for COVID-19 Vaccine Booster
September 19, 2024
·
5 min read
1 of 30,442
Next
